Recruiting

Vercise DBS

Sponsor:

Boston Scientific Corporation

Code:

NCT02071134

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Deep Brain Stimulation (DBS)

Study Details

Brief summary:

The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease.

The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated.

Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated.

Conditions

Parkinson's Disease

Study ID

NCT02071134

Start date

Mar 4, 2014

Status verified date

Aug, 2026

Completion date

Dec, 2038

Anticipated

Primary completion date

Dec, 2038

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Key Inclusion Criteria:

  • Meets criteria established in locally applicable Vercise System Direction for Use
  • At least 18 years old

Key Exclusion Criteria:

  • Meets any contraindication in the Vercise System locally applicable Directions for Use

Subjects with significant cognitive or psychiatric impairment may be excluded in the evaluation of GXT.

Study Design

Enrollment

1500 participants

Anticipated

Interventions and Outcome Measures

Arms

Parkinson's disease

Subjects with Parkinson's disease who will receive Vercise DBS for deep brain stimulation.

Interventions

Deep Brain Stimulation (DBS)

Subjects receiving Deep Brain Stimulation (DBS) for the treatment of their Parkinson's disease symptoms will be offered participation in this registry.

Primary outcome measure

  • Improvement in patient's quality of life (QoL) during the study as compared with baseline [ Time Frame: up to 3 years ]

Central Contacts and Locations

Locations

Cedars Sinai Medical Center

Recruiting

Los Angeles, California, United States, 90048

Contacts

Boston Scientific Clinical Research

855-213-9890BSNClinicalTrials@bsci.com

University of Colorado

Recruiting

Aurora, Colorado, United States, 80220

Contacts

Boston Scientific Clinical Research

855-213-9890BSNClinicalTrials@bsci.com

St. Mary's Hospital and Medical Center

Recruiting

Grand Junction, Colorado, United States, 81501

Contacts

Boston Scientific Clinical Research

855-213-9890BSNClinicalTrials@bsci.com

University of Florida Shands Hospital

Recruiting

Gainesville, Florida, United States, 32610

Contacts

Boston Scientific Clinical Research Manager

855-213-9890BSNClinicalTrials@bsci.com

University of Miami Hospital

Recruiting

Miami, Florida, United States, 33136

Contacts

Boston Scientific Clinical Research Manager

855-213-9890BSNClinicalTrials@bsci.com

University of South Florida

Recruiting

Tampa, Florida, United States, 33612

Contacts

Boston Scientific Clinical Research Manager

855-213-9890BSNClinicalTrials@bsci.com

St. Luke Regional Medical Center

Recruiting

Boise, Idaho, United States, 83702

Contacts

Boston Scientific Clinical Research Manager

855-213-9890BSNClinicalTrials@bsci.com

Rush University Medical Center

Recruiting

Chicago, Illinois, United States, 60612

Contacts

Boston Scientific Clinical Research Manager

855-213-9890BSNClinicalTrials@bsci.com

Northwell Health Neuroscience Institute

Recruiting

Great Neck, New York, United States, 11021

Contacts

Boston Scientific Clinical Research Manager

855-213-9890BSNClinicalTrials@bsci.com

University at Buffalo

Recruiting

Williamsville, New York, United States, 14221

Contacts

Boston Scientific Clinical Research

855-213-9890BSNClinicalTrials@bsci.com

Wake Forest University School of Medicine

Recruiting

Winston-Salem, North Carolina, United States, 27157

Contacts

Boston Scientific Clinical Research Manager

855-213-9890BSNClinicalTrials@bsci.com

Ohio State University

Recruiting

Columbus, Ohio, United States, 43210

Contacts

Boston Scientific Clinical Research Manager

855-213-9890BSNClinicalTrials@bsci.com

Houston Methodist Research Institute

Recruiting

Houston, Texas, United States, 77030

Contacts

Boston Scientific Clinical Research

855-213-9890BSNClinicalTrials@bsci.com

University of Texas Health Medical Arts and Research Center

Recruiting

San Antonio, Texas, United States, 78229

Contacts

Boston Scientific Clinical Research Manager

855-213-9890BSNClinicalTrials@bsci.com

Texas Institute for Neurological Disorders

Recruiting

Sherman, Texas, United States, 75092

Contacts

Boston Scientific Clinical Research

855-213-9890BSNClinicalTrials@bsci.com

Evergreen Health

Recruiting

Kirkland, Washington, United States, 98034

Contacts

Boston Scientific Clinical Research

855-213-9890BSNClinicalTrials@bsci.com

University of Washington Medical Center

Recruiting

Seattle, Washington, United States, 98195

Contacts

Boston Scientific Clinical Research

855-213-9890BSNClinicalTrials@bsci.com

Inland Northwest Research

Recruiting

Spokane, Washington, United States, 99202

Contacts

Boston Scientific Clinical Research Manager

855-213-9890BSNClinicalTrials@bsci.com

More Information

Sponsor

Boston Scientific Corporation

Last update posted

Aug 11, 2026

Last verified

Aug, 2026

Keywords

  • Deep brain stimulation
  • Parkinson's disease
  • Vercise

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Boston Scientific Corporation on 2026-08-11.